Clinical application of ghrelin administration for gastric cancer patients undergoing gastrectomy

Shuji Takiguchi, Akihiro Takata, Kohei Murakami, Yasuhiro Miyazaki, Yoshitomo Yanagimoto, Yukinori Kurokawa, Tsuyoshi Takahashi, Masaki Mori, Yuichiro Doki

Research output: Contribution to journalReview article

17 Citations (Scopus)

Abstract

Loss of body weight is a common (and the most serious) sequela after gastrectomy. It impairs quality of life, increases various diseases including infection, and may affect long-term survival. Ghrelin, an intrinsic ligand of the growth hormone secretagogue receptor, was discovered in the stomach in 1999. In addition to growth hormone secretion, ghrelin has pleiotropic functions including appetite stimulation, increasing bowel movement and absorption, and anti-inflammatory reactions. In consequence, ghrelin comprehensively leads positive energy balance and weight gain. The fundic gland of the stomach produces the majority of ghrelin, and plasma ghrelin declines to 10-30 % of the preoperative level after total gastrectomy and 50-70 % after distal gastrectomy. Although plasma ghrelin is never restored after total gastrectomy, it gradually recovers to the preoperative level within a few years after distal gastrectomy. Chronic gastritis due to Helicobacter pylori infection and vagotomy are additional factors that perturb the ghrelin secretion of gastric cancer patients after gastrectomy. A randomized clinical trial that revealed that recombinant ghrelin administration successfully increased both food intake and appetite, and ameliorated weight loss after total gastrectomy. Ghrelin administration could thus be a promising strategy to transiently improve the nutritional status of patients who who have undergone gastrectomy, but its effect in the long term remains unclear. Further studies are warranted to elucidate the mechanism of ghrelin and to create and evaluate the analogs that could be administered orally or subcutaneously.

Original languageEnglish
Pages (from-to)200-205
Number of pages6
JournalGastric Cancer
Volume17
Issue number2
DOIs
Publication statusPublished - Apr 2014

All Science Journal Classification (ASJC) codes

  • Oncology
  • Gastroenterology
  • Cancer Research

Fingerprint Dive into the research topics of 'Clinical application of ghrelin administration for gastric cancer patients undergoing gastrectomy'. Together they form a unique fingerprint.

  • Cite this

    Takiguchi, S., Takata, A., Murakami, K., Miyazaki, Y., Yanagimoto, Y., Kurokawa, Y., Takahashi, T., Mori, M., & Doki, Y. (2014). Clinical application of ghrelin administration for gastric cancer patients undergoing gastrectomy. Gastric Cancer, 17(2), 200-205. https://doi.org/10.1007/s10120-013-0300-8